TFF Pharmaceuticals, Inc. financial data

Symbol
TFFP on Nasdaq
Industry
Pharmaceutical Preparations
Location
2600 Via Fortuna, Suite 360, Austin, TX
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 20, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 158 % -85%
Debt-to-equity 58.2 % +606%
Return On Equity -310 % -113%
Return On Assets -196 % -45.5%
Operating Margin -1.61K % +37.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.44M shares
Common Stock, Shares, Outstanding 3.54M shares -94%
Entity Public Float 16.5M USD -88.1%
Common Stock, Value, Issued 3.54K USD -94%
Weighted Average Number of Shares Outstanding, Basic 4.37M shares +130%
Weighted Average Number of Shares Outstanding, Diluted 4.37M shares +130%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.16M USD +24.6%
Research and Development Expense 10.8M USD -18%
General and Administrative Expense 9.05M USD -22.1%
Operating Income (Loss) -18.7M USD +21.8%
Nonoperating Income (Expense) 182K USD +246%
Net Income (Loss) Attributable to Parent -18.5M USD +22.4%
Earnings Per Share, Basic -5.62 USD/shares +84.5%
Earnings Per Share, Diluted -5.62 USD/shares +84.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.6M USD -73.3%
Assets, Current 3.51M USD -67.8%
Property, Plant and Equipment, Net 1.64M USD -20.6%
Operating Lease, Right-of-Use Asset 58K USD -58.3%
Other Assets, Noncurrent 95.3K USD +1140%
Assets 7.08M USD -52.4%
Accounts Payable, Current 1.64M USD +67.2%
Employee-related Liabilities, Current 4.43K USD
Accrued Liabilities, Current 1.99M USD
Contract with Customer, Liability, Current 251K USD
Liabilities, Current 3.94M USD +245%
Operating Lease, Liability, Noncurrent 10.9K USD -88.1%
Liabilities 3.94M USD +230%
Accumulated Other Comprehensive Income (Loss), Net of Tax -167K USD +18.2%
Retained Earnings (Accumulated Deficit) -132M USD -16.3%
Stockholders' Equity Attributable to Parent 3.14M USD -77.1%
Liabilities and Equity 7.08M USD -52.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.14M USD +28%
Net Cash Provided by (Used in) Financing Activities 901K USD
Net Cash Provided by (Used in) Investing Activities -137K USD +71.2%
Common Stock, Shares Authorized 180M shares +100%
Common Stock, Shares, Issued 3.54M shares -94%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.27M USD +48.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.61M USD -73.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 15.3K USD
Deferred Tax Assets, Valuation Allowance 27.5M USD +23.2%
Deferred Tax Assets, Gross 27.5M USD +23.2%
Operating Lease, Liability 52.4K USD -61.2%
Payments to Acquire Property, Plant, and Equipment 137K USD -71.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -18.5M USD +20.7%
Lessee, Operating Lease, Liability, to be Paid 53.8K USD
Operating Lease, Liability, Current 52.4K USD -36.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 38K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 38.4K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.41K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 91K USD
Deferred Tax Assets, Operating Loss Carryforwards 18M USD +17.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 38K USD
Operating Lease, Payments 22.3K USD +3.66%
Additional Paid in Capital 122M USD +14.2%
Depreciation, Depletion and Amortization 140K USD +13.8%
Share-based Payment Arrangement, Expense 568K USD -25.9%
Operating Leases, Future Minimum Payments Due 194K USD +824%
Interest Expense 15.6K USD